IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

1.32

h-Index

2022-2023

 64

Rank

2022-2023

 10005

SJR

2022-2023

 0.519

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Sarcoidosis Vasculitis and Diffuse Lung Diseases
Abbreviation Sarcoidosis Vasc. Diffuse Lung Dis.
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3); Internal Medicine (Q3); Pulmonary and Respiratory Medicine (Q3)
h-index 64
Overall Rank/Ranking 10005
SCImago Journal Rank (SJR) 0.519
Impact Score 1.32
Publisher Mattioli1885
Country Italy
ISSN 11240490
Best Quartile Q2
Coverage History 1996-2021




About Sarcoidosis Vasculitis and Diffuse Lung Diseases


Sarcoidosis Vasculitis and Diffuse Lung Diseases is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3); Internal Medicine (Q3); Pulmonary and Respiratory Medicine (Q3). It is published by Mattioli1885. The overall rank of Sarcoidosis Vasculitis and Diffuse Lung Diseases is 10005. According to SCImago Journal Rank (SJR), this journal is ranked 0.519. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 64. The best quartile for this journal is Q2.

The ISSN of Sarcoidosis Vasculitis and Diffuse Lung Diseases journal is 11240490. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Sarcoidosis Vasculitis and Diffuse Lung Diseases is cited by a total of 156 articles during the last 3 years (Preceding 2022).


Sarcoidosis Vasculitis and Diffuse Lung Diseases Impact IF 2022-2023


The Impact IF 2022 of Sarcoidosis Vasculitis and Diffuse Lung Diseases is 1.32, which is computed in 2023 as per its definition. Sarcoidosis Vasculitis and Diffuse Lung Diseases IF is decreased by a factor of 0.31 and approximate percentage change is -19.02% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Sarcoidosis Vasculitis and Diffuse Lung Diseases Impact IF 2023 Prediction


Impact IF 2022 of Sarcoidosis Vasculitis and Diffuse Lung Diseases is 1.32. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Sarcoidosis Vasculitis and Diffuse Lung Diseases. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 1.32
2021 1.63
2020 0.48
2019 0.33
2018 0.91
2017 1.32
2016 1.83
2015 1.88
2014 1.19

Sarcoidosis Vasculitis and Diffuse Lung Diseases h-index


  Table Setting

Sarcoidosis Vasculitis and Diffuse Lung Diseases has an h-index of 64. It means 64 articles of this journal have more than 64 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Sarcoidosis Vasculitis and Diffuse Lung Diseases ISSN


The ISSN of Sarcoidosis Vasculitis and Diffuse Lung Diseases is 11240490. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Sarcoidosis Vasculitis and Diffuse Lung Diseases Rank and SCImago Journal Rank (SJR)


The overall rank of Sarcoidosis Vasculitis and Diffuse Lung Diseases is 10005. According to SCImago Journal Rank (SJR), this journal is ranked 0.519. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Sarcoidosis Vasculitis and Diffuse Lung Diseases by Year


Year SJR
2023/2024 Coming Soon
2022 0.519
2021 0.420
2020 0.250
2019 0.306
2018 0.434
2017 0.765
2016 0.578
2015 0.710
2014 0.585

Ranking of Sarcoidosis Vasculitis and Diffuse Lung Diseases by Year


Year Ranking
2023/2024 Coming Soon
2022 10005
2021 11650
2020 16717
2019 14200
2018 10657
2017 6127
2016 8157
2015 6701
2014 7864

Sarcoidosis Vasculitis and Diffuse Lung Diseases Publisher


Table Setting

Sarcoidosis Vasculitis and Diffuse Lung Diseases is published by Mattioli1885. It's publishing house is located in Italy. Coverage history of this journal is as following: 1996-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Sarcoidosis Vasculitis and Diffuse Lung Diseases is Sarcoidosis Vasc. Diffuse Lung Dis.. This abbreviation ('Sarcoidosis Vasc. Diffuse Lung Dis.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Sarcoidosis Vasculitis and Diffuse Lung Diseases


If your research field is/are related to Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3); Internal Medicine (Q3); Pulmonary and Respiratory Medicine (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Sarcoidosis Vasculitis and Diffuse Lung Diseases?

Sarcoidosis Vasculitis and Diffuse Lung Diseases latest impact IF is 1.32. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 1.88 (2015) and 0.33 (2019), respectively, in the last 9 years. Moreover, its average IS is 1.21 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Sarcoidosis Vasculitis and Diffuse Lung Diseases?

The Sarcoidosis Vasculitis and Diffuse Lung Diseases has an SJR (SCImago Journal Rank) of 0.519, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.765 in 2017 and the lowest being 0.250 in 2020. Furthermore, the average SJR of the Sarcoidosis Vasculitis and Diffuse Lung Diseases over the previous 9-year period stands at 1.21.


What's the latest h-index of the Sarcoidosis Vasculitis and Diffuse Lung Diseases?

The latest h-index of the Sarcoidosis Vasculitis and Diffuse Lung Diseases is 64.


Who's the publisher of the Sarcoidosis Vasculitis and Diffuse Lung Diseases?

The Sarcoidosis Vasculitis and Diffuse Lung Diseases is published by the Mattioli1885, with its country of publication being the Italy.


What's the current ranking of the Sarcoidosis Vasculitis and Diffuse Lung Diseases?

The Sarcoidosis Vasculitis and Diffuse Lung Diseases is currently ranked 10005 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 6127 in 2017 and its lowest position of 16717 in 2020.


What's the abbreviation or short name for the Sarcoidosis Vasculitis and Diffuse Lung Diseases?

The standard ISO4 abbreviation for the Sarcoidosis Vasculitis and Diffuse Lung Diseases is Sarcoidosis Vasc. Diffuse Lung Dis..


Is the "Sarcoidosis Vasculitis and Diffuse Lung Diseases" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Sarcoidosis Vasculitis and Diffuse Lung Diseases is classified as a journal that the Mattioli1885 publishes.


What's the scope or major areas of the Sarcoidosis Vasculitis and Diffuse Lung Diseases?

The Sarcoidosis Vasculitis and Diffuse Lung Diseases encompasses the following areas:

  • Medicine (miscellaneous)
  • Immunology and Allergy
  • Internal Medicine
  • Pulmonary and Respiratory Medicine

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Sarcoidosis Vasculitis and Diffuse Lung Diseases?

The Sarcoidosis Vasculitis and Diffuse Lung Diseases is assigned the following International Standard Serial Numbers (ISSN): 11240490.


What's the best quartile of the Sarcoidosis Vasculitis and Diffuse Lung Diseases?

The best quartile for the Sarcoidosis Vasculitis and Diffuse Lung Diseases is Q2 (2022).


What's the coverage history of the Sarcoidosis Vasculitis and Diffuse Lung Diseases?

The Sarcoidosis Vasculitis and Diffuse Lung Diseases coverage history can be summarized as follows: 1996-2021.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Business: Theory and Practice journal 13414 Vilnius Gediminas Technical University 21 2.47
SPE Production and Operations Symposium, Proceedings conference and proceedings 15907 21 0.00
Journal of Geriatric Physical Therapy journal 5578 Lippincott Williams and Wilkins Ltd. 43 1.80
IEEE/OSA Journal of Display Technology journal 12809 IEEE Computer Society 68 0.00
World Englishes journal 4960 Wiley-Blackwell 60 1.97
Proceedings of the Technical Association of the Graphic Arts, TAGA conference and proceedings 30903 Technical Association of the Graphic 8 0.00
Museum Management and Curatorship journal 8168 Routledge 37 2.65
Asian Textile Journal trade journal 27455 G P S Kwatra 10 0.01
Oral Radiology journal 9461 Springer Japan 20 2.06
Journal of Sociology journal 6009 SAGE Publications Ltd 58 3.21

Check complete list




Year wise Impact Score (IS) of Sarcoidosis Vasculitis and Diffuse Lung Diseases

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.32
2021 1.63
2020 0.48
2019 0.33
2018 0.91
2017 1.32
2016 1.83
2015 1.88
2014 1.19



Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Immunology and Allergy

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Annual Review of Immunology
Annual Reviews Inc. | United States

Immunity
Cell Press | United States

Science immunology
American Association for the Advancement of Science | United States

Nature Immunology
Nature Publishing Group | United Kingdom

Annals of the Rheumatic Diseases
BMJ Publishing Group | United Kingdom

Journal of Experimental Medicine
Rockefeller University Press | United States

Trends in Immunology
Elsevier Ltd. | United Kingdom

Lancet Rheumatology, The
Elsevier Ltd. | United Kingdom

Arthritis and Rheumatology
John Wiley and Sons Ltd | United Kingdom

See All

Top Journals/Conferences in Internal Medicine

Lancet Diabetes and Endocrinology,The
Elsevier Ltd. | United Kingdom

Lancet Regional Health - Europe, The
Elsevier Ltd. | United Kingdom

Nature Metabolism
Springer Berlin | Germany

Diabetes Care
American Diabetes Association Inc. | United States

JAMA Internal Medicine
American Medical Association | United States

Annals of Internal Medicine
American College of Physicians | United States

Diabetologia
Springer Verlag | Germany

Lancet Regional Health - Americas, The
Elsevier Ltd. | United Kingdom

Journal of Internal Medicine
Wiley-Blackwell Publishing Ltd | United Kingdom

JHEP Reports
Elsevier BV | Netherlands

See All

Top Journals/Conferences in Pulmonary and Respiratory Medicine

Lancet Respiratory Medicine,The
Elsevier Ltd. | United Kingdom

American Journal of Respiratory and Critical Care Medicine
American Thoracic Society | United States

Journal of Thoracic Oncology
International Association for the Study of Lung Cancer | United States

European Respiratory Journal
European Respiratory Society | Switzerland

Thorax
BMJ Publishing Group | United Kingdom

Sleep Medicine Reviews
Elsevier BV | United Kingdom

Journal of Heart and Lung Transplantation
Elsevier USA | United States

European Respiratory Review
European Respiratory Society | Switzerland

Chest
American College of Chest Physicians | United States

Annals of the American Thoracic Society
American Thoracic Society | United States

See All